Your browser doesn't support javascript.
loading
The Microbiota-Gut-Brain Axis: Clinical Applications in Obesity and Type 2 Diabetes
Moser, Brandy; Milligan, Megan A.; Dao, Maria C..
  • Moser, Brandy; University of New Hampshire. Durham. US
  • Milligan, Megan A.; University of New Hampshire. Durham. US
  • Dao, Maria C.; University of New Hampshire. Durham. US
Rev. invest. clín ; 74(6): 302-313, Nov.-Dec. 2022. graf
Article Dans Anglais | LILACS-Express | LILACS | ID: biblio-1431819
ABSTRACT
ABSTRACT Recent investigations highlight the importance of the gut microbiota and bacteria-derived metabolites as key components in obesity and metabolic health. The microbiota-gut-brain axis presents promising targets for future obesity treatments and prevention. However, the current state of evidence and existing clinical applications of the microbiota-gut-brain axis have yet to be summarized in a thorough review. Therefore, we sought to examine current evidence on the effect of lifestyle, dietary, pharmacological, and surgical interventions on the microbiota-gut-brain axis. In addition, this review highlights potential next steps in research toward characterizing the role of the microbiota-gut-brain axis in metabolic health, along with possible interventions to address obesity.


Texte intégral: Disponible Indice: LILAS (Amériques) langue: Anglais Texte intégral: Rev. invest. clín Thème du journal: Médicament Année: 2022 Type: Article Pays d'affiliation: États-Unis d'Amérique Institution/Pays d'affiliation: University of New Hampshire/US

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS


Texte intégral: Disponible Indice: LILAS (Amériques) langue: Anglais Texte intégral: Rev. invest. clín Thème du journal: Médicament Année: 2022 Type: Article Pays d'affiliation: États-Unis d'Amérique Institution/Pays d'affiliation: University of New Hampshire/US